Sirolimus and cyclosporin for renal transplantation

Lancet. 2000 Jul 15;356(9225):179-80. doi: 10.1016/s0140-6736(00)02473-9.
No abstract available

MeSH terms

  • Calcineurin Inhibitors
  • Carrier Proteins / metabolism
  • Cell Cycle / drug effects
  • Cyclosporine / adverse effects
  • Cyclosporine / metabolism
  • Cyclosporine / therapeutic use*
  • Drug Synergism
  • Graft Survival / drug effects
  • Humans
  • Immunophilins / metabolism
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / metabolism
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation*
  • Peptidylprolyl Isomerase / metabolism
  • Phosphotransferases (Alcohol Group Acceptor)*
  • Protein Binding
  • Protein Biosynthesis / drug effects
  • RNA, Messenger / drug effects
  • Sirolimus / adverse effects
  • Sirolimus / metabolism
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases
  • Tacrolimus / metabolism
  • Tacrolimus / therapeutic use
  • Tacrolimus Binding Proteins

Substances

  • Calcineurin Inhibitors
  • Carrier Proteins
  • Immunosuppressive Agents
  • RNA, Messenger
  • Cyclosporine
  • Phosphotransferases (Alcohol Group Acceptor)
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Tacrolimus Binding Proteins
  • Immunophilins
  • Peptidylprolyl Isomerase
  • Sirolimus
  • Tacrolimus